Insiders · CING

CING insider transactions

Cingulate Inc. (CING) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CING

• 30d
  SEC Form 4 filed by EVP and CSO Silva Raul R.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 88d
  EVP and CSO Silva Raul R. was granted 4,526 shares and covered exercise/tax liability with 1,828 shares, increasing direct ownership by 139% to 4,645 units (SEC Form 4)

  4 - Cingulate Inc. (0001862150) (Issuer)
• 88d
  EVP, CLO and CCO Patel Nilay Dahyabhai was granted 5,475 shares and covered exercise/tax liability with 2,086 shares (SEC Form 4)

  4 - Cingulate Inc. (0001862150) (Issuer)
• 88d
  Chief Executive Officer Schaffer Shane J. was granted 6,862 shares and covered exercise/tax liability with 2,959 shares, increasing direct ownership by 2,256% to 4,076 units (SEC Form 4)

  4 - Cingulate Inc. (0001862150) (Issuer)
• 88d
  EVP and CFO Callahan Jennifer L. was granted 15,329 shares and covered exercise/tax liability with 6,427 shares, increasing direct ownership by 176% to 13,961 units (SEC Form 4)

  4 - Cingulate Inc. (0001862150) (Issuer)
• 88d
  EVP and Chief Medical Officer Brams Matthew covered exercise/tax liability with 1,025 shares and was granted 4,526 shares, increasing direct ownership by 75% to 8,157 units (SEC Form 4)

  4 - Cingulate Inc. (0001862150) (Issuer)
• 117d
  SVP and CFO Callahan Jennifer L. bought $24,515 worth of shares (4,864 units at $5.04), increasing direct ownership by 2,494% to 5,059 units (SEC Form 4)

  4 - Cingulate Inc. (0001862150) (Issuer)
• 117d
  Chief Executive Officer Schaffer Shane J. bought $34,317 worth of shares (6,809 units at $5.04) (SEC Form 4)

  4 - Cingulate Inc. (0001862150) (Issuer)
• 117d
  Director Werth Peter J. bought $98,053 worth of shares (19,455 units at $5.04) (SEC Form 4)

  4 - Cingulate Inc. (0001862150) (Issuer)
• 117d
  EVP and Chief Medical Officer Brams Matthew bought $9,808 worth of shares (1,946 units at $5.04), increasing direct ownership by 72% to 4,656 units (SEC Form 4)

  4 - Cingulate Inc. (0001862150) (Issuer)
• 153d
  SEC Form 4 filed by EVP and CSO Silva Raul R.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 209d
  SEC Form 4 filed by EVP and CSO Silva Raul R.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 209d
  SEC Form 4 filed by Chief Commercial Officer Downey Bryan Wade

  4 - Cingulate Inc. (0001862150) (Issuer)
• 209d
  SEC Form 3 filed by new insider Downey Bryan Wade

  3 - Cingulate Inc. (0001862150) (Issuer)
• 332d
  SEC Form 4 filed by CLO and CCO Patel Nilay Dahyabhai

  4 - Cingulate Inc. (0001862150) (Issuer)
• 332d
  SEC Form 3 filed by new insider Patel Nilay Dahyabhai

  3 - Cingulate Inc. (0001862150) (Issuer)
• 333d
  SEC Form 4 filed by EVP and CSO Silva Raul R.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 333d
  SEC Form 4 filed by SVP and CFO Callahan Jennifer L.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 333d
  SEC Form 4 filed by Chief Executive Officer Schaffer Shane J.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 333d
  SEC Form 4 filed by EVP and Chief Medical Officer Brams Matthew

  4 - Cingulate Inc. (0001862150) (Issuer)
• 333d
  SEC Form 4 filed by EVP and COO Myers Laurie

  4 - Cingulate Inc. (0001862150) (Issuer)
• 341d
  SEC Form 4 filed by EVP and CSO Silva Raul R.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 349d
  SEC Form 4 filed by Director Roberts John A

  4 - Cingulate Inc. (0001862150) (Issuer)
• 349d
  SEC Form 4 filed by Director Werth Peter J.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 349d
  SEC Form 4 filed by Director Lawrence Bryan Jay

  4 - Cingulate Inc. (0001862150) (Issuer)
• 349d
  SEC Form 4 filed by Director Ervin Jeffrey S

  4 - Cingulate Inc. (0001862150) (Issuer)
• 472d
  SEC Form 4 filed by EVP and COO Myers Laurie

  4 - Cingulate Inc. (0001862150) (Issuer)
• 472d
  SEC Form 4 filed by SVP and CFO Callahan Jennifer L.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 472d
  SEC Form 4 filed by Chief Executive Officer Schaffer Shane J.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 472d
  SEC Form 4 filed by EVP and Chief Medical Officer Brams Matthew

  4 - Cingulate Inc. (0001862150) (Issuer)
• 472d
  SEC Form 4 filed by EVP and CSO Silva Raul R.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 501d
  SEC Form 4 filed by SVP and CFO Callahan Jennifer L.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 501d
  SEC Form 4 filed by EVP and CSO Silva Raul R.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 501d
  SEC Form 4 filed by EVP and COO Myers Laurie

  4 - Cingulate Inc. (0001862150) (Issuer)
• 501d
  SEC Form 4 filed by EVP and Chief Medical Officer Brams Matthew

  4 - Cingulate Inc. (0001862150) (Issuer)
• 501d
  SEC Form 4 filed by Chief Executive Officer Schaffer Shane J.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 516d
  SEC Form 4 filed by EVP and CSO Silva Raul R.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 516d
  SEC Form 4 filed by EVP and Chief Medical Officer Brams Matthew

  4 - Cingulate Inc. (0001862150) (Issuer)
• 614d
  SEC Form 4 filed by EVP and CSO Silva Raul R.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 614d
  SEC Form 4 filed by EVP and Chief Medical Officer Brams Matthew

  4 - Cingulate Inc. (0001862150) (Issuer)
• 657d
  EVP and COO Myers Laurie sold $841 worth of shares (202 units at $4.17), closing all direct ownership in the company (SEC Form 4)

  4 - Cingulate Inc. (0001862150) (Issuer)
• 705d
  SEC Form 4 filed by EVP and CSO Silva Raul R.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 705d
  SEC Form 4 filed by EVP and Chief Medical Officer Brams Matthew

  4 - Cingulate Inc. (0001862150) (Issuer)
• 724d
  SEC Form 4 filed by EVP and Chief Medical Officer Brams Matthew

  4 - Cingulate Inc. (0001862150) (Issuer)
• 724d
  SEC Form 4 filed by SVP and CFO Callahan Jennifer L.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 724d
  SEC Form 4 filed by Director Ervin Jeffrey S

  4 - Cingulate Inc. (0001862150) (Issuer)
• 724d
  SEC Form 4 filed by Director Roberts John A

  4 - Cingulate Inc. (0001862150) (Issuer)
• 724d
  SEC Form 4 filed by Director Werth Peter J.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 724d
  SEC Form 4 filed by EVP and COO Myers Laurie

  4 - Cingulate Inc. (0001862150) (Issuer)
• 724d
  SEC Form 4 filed by Chief Executive Officer Schaffer Shane J.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 724d
  SEC Form 4 filed by Director Lawrence Bryan Jay

  4 - Cingulate Inc. (0001862150) (Issuer)
• 724d
  SEC Form 4 filed by EVP and CSO Silva Raul R.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 786d
  Werth Peter J. exercised 1,036,008 shares at a strike of $0.00 (SEC Form 4)

  4 - Cingulate Inc. (0001862150) (Issuer)
• 797d
  SEC Form 4 filed by Silva Raul R.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 797d
  SEC Form 4 filed by Brams Matthew

  4 - Cingulate Inc. (0001862150) (Issuer)
• 802d
  SEC Form 4 filed by Werth Peter J.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 807d
  Callahan Jennifer L. bought $1,490 worth of shares (55 units at $27.10), increasing direct ownership by 2% to 2,333 units (SEC Form 4)

  4 - Cingulate Inc. (0001862150) (Issuer)
• 823d
  SEC Form 4 filed by Callahan Jennifer L.

  4 - Cingulate Inc. (0001862150) (Issuer)
• 823d
  SEC Form 4 filed by Myers Laurie

  4 - Cingulate Inc. (0001862150) (Issuer)
• 823d
  SEC Form 4 filed by Brams Matthew

  4 - Cingulate Inc. (0001862150) (Issuer)